1) topotecan-resistance
拓扑替康耐药
2) Topotecan
拓扑替康
1.
Determination of the Content of Topotecan in Samples by HPLC;
高效液相色谱法测定拓扑替康含量
2.
An observation on short-term effect of the combination of topotecan and cisplatin in the treatment of advanced non-small cell lung cancer;
拓扑替康联合顺铂治疗晚期非小细胞肺癌的近期疗效观察
3.
Topotecan for Small Cell Lung Cancer:A Systematic Review;
拓扑替康治疗小细胞肺癌的系统评价
3) topotecan hydrochloride
盐酸拓扑替康
1.
Studies on the preparation of liposomal topotecan hydrochloride and the influencing factors;
盐酸拓扑替康脂质体的制备及影响因素考察
2.
Study on in vitro cytotoxicity and in vivo antitumor effect of liposomes containing topotecan hydrochloride;
盐酸拓扑替康脂质体的体外细胞毒及体内抗肿瘤作用
3.
Studies on the polymorph of topotecan hydrochloride and its stability;
盐酸拓扑替康的晶型与稳定性研究
4) topotecan/therapeutic use
拓扑替康/治疗应用
5) Topotecan
拓朴替康
1.
To observe the effect and toxicity of topotecan in the treatment for small cell lung cancer(SCLC).
[目的]观察拓朴替康治疗小细胞肺癌的疗效和毒副反应。
6) topotecan
拓普替康
1.
Significance of gene expression aleration in topotecan-resistance ovarian carcinoma ceil line;
拓普替康耐药卵巢癌细胞基因的表达变化及意义
2.
A Phase Ⅰ Clinical Trial of Topotecan Plus Radiotherapy in Patients with Local Advanced Stage of Non-small Cell Lung Cancer;
放射治疗合并盐酸拓普替康治疗局部晚期非小细胞肺癌的Ⅰ期临床研究
补充资料：拓扑替康
分子式：C23H23N3O5
分子量：暂无
CAS号：123948-87-8
性质：暂无
制备方法：暂无
用途：抗肿瘤药。
分子量：暂无
CAS号：123948-87-8
性质：暂无
制备方法：暂无
用途：抗肿瘤药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条